WallStreetZenWallStreetZen

NYSE: EW
Edwards Lifesciences Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for EW

Based on 16 analysts offering 12 month price targets for Edwards Lifesciences Corp

Min Forecast
$85.00+2.16%
Avg Forecast
$97.38+17.04%
Max Forecast
$110.00+32.21%

Should I buy or sell EW stock?

Based on 16 analysts offering ratings for Edwards Lifesciences Corp.

Strong Buy
Strong Buy
9 analysts 56.25%
Buy
3 analysts 18.75%
Hold
4 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model "Buy" agrees with analyst consensus with a "Strong Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their EW stock forecasts and price targets.

EW stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-04-27
lockedlocked$00.00+00.00%2026-04-24
lockedlocked$00.00+00.00%2026-04-24
lockedlocked$00.00+00.00%2026-04-24
lockedlocked$00.00+00.00%2026-04-24
Baird
Top 21%
80
HoldMaintains$87.00+4.57%2026-04-24
Mizuho
Top 13%
88
BuyMaintains$95.00+14.18%2026-04-13
Goldman Sachs
Bottom 7%
7
Strong BuyMaintains$95.00+14.18%2026-02-11
Piper Sandler
Top 28%
73
Strong BuyReiterates$100.00+20.19%2026-02-11Find out why
Wells Fargo
Top 22%
79
Strong BuyMaintains$100.00+20.19%2026-02-11

1 of 2

Forecast return on equity

Is EW forecast to generate an efficient return?

Company
23.82%
Industry
19.97%
Market
159.32%
EW's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is EW forecast to generate an efficient return on assets?

Company
18.47%
Industry
14.35%
EW is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

EW earnings per share forecast

What is EW's earnings per share in the next 3 years based on estimates from 37 analysts?

Avg 1 year Forecast
$3.07+62.55%
Avg 2 year Forecast
$3.44+81.92%
Avg 3 year Forecast
$3.89+105.98%
EW's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

EW revenue forecast

What is EW's revenue in the next 3 years based on estimates from 38 analysts?

Avg 1 year Forecast
$6.9B+10.16%
Avg 2 year Forecast
$7.6B+21.04%
Avg 3 year Forecast
$8.4B+33.02%
EW's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

EW earnings growth forecast

How is EW forecast to perform vs Medical Devices companies and vs the US market?

Company
27.01%
Industry
23.59%
Market
33.74%
EW's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
EW's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
EW's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

EW revenue growth forecast

How is EW forecast to perform vs Medical Devices companies and vs the US market?

Company
9.91%
Industry
8.76%
Market
14.13%
EW's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
EW's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

EW vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
EW$83.20$97.38+17.04%Strong Buy
PHG$27.23N/AN/A
DXCM$60.36$81.67+35.30%Strong Buy
STE$214.46N/AN/A
ZBH$82.83$99.07+19.61%Hold
View Top Medical Device Stocks

Edwards Lifesciences Stock Forecast FAQ

Is Edwards Lifesciences Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 16 Wall Street analysts covering (NYSE: EW) stock is to Strong Buy EW stock.

Out of 16 analysts, 9 (56.25%) are recommending EW as a Strong Buy, 3 (18.75%) are recommending EW as a Buy, 4 (25%) are recommending EW as a Hold, 0 (0%) are recommending EW as a Sell, and 0 (0%) are recommending EW as a Strong Sell.

If you're new to stock investing, here's how to buy Edwards Lifesciences stock.

What is EW's earnings growth forecast for 2026-2028?

(NYSE: EW) Edwards Lifesciences's forecast annual earnings growth rate of 27.01% is forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 23.59%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.74%.

Edwards Lifesciences's earnings in 2026 is $1,096,200,000.On average, 37 Wall Street analysts forecast EW's earnings for 2026 to be $1,768,972,760, with the lowest EW earnings forecast at $1,326,067,400, and the highest EW earnings forecast at $1,843,999,500. On average, 37 Wall Street analysts forecast EW's earnings for 2027 to be $1,979,715,560, with the lowest EW earnings forecast at $1,489,709,760, and the highest EW earnings forecast at $2,122,110,900.

In 2028, EW is forecast to generate $2,241,646,980 in earnings, with the lowest earnings forecast at $2,059,636,600 and the highest earnings forecast at $2,460,681,300.

What is EW's revenue growth forecast for 2026-2028?

(NYSE: EW) Edwards Lifesciences's forecast annual revenue growth rate of 9.91% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.76%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.13%.

Edwards Lifesciences's revenue in 2026 is $6,303,500,000.On average, 38 Wall Street analysts forecast EW's revenue for 2026 to be $3,998,355,200,000, with the lowest EW revenue forecast at $3,735,790,400,000, and the highest EW revenue forecast at $4,118,697,400,000. On average, 37 Wall Street analysts forecast EW's revenue for 2027 to be $4,393,354,000,000, with the lowest EW revenue forecast at $4,028,296,800,000, and the highest EW revenue forecast at $4,579,337,400,000.

In 2028, EW is forecast to generate $4,828,083,000,000 in revenue, with the lowest revenue forecast at $4,359,957,600,000 and the highest revenue forecast at $5,112,528,200,000.

What is EW's forecast return on assets (ROA) for 2026-2029?

(NYSE: EW) forecast ROA is 18.47%, which is higher than the forecast US Medical Devices industry average of 14.35%.

What is EW's Price Target?

According to 16 Wall Street analysts that have issued a 1 year EW price target, the average EW price target is $97.38, with the highest EW stock price forecast at $110.00 and the lowest EW stock price forecast at $85.00.

On average, Wall Street analysts predict that Edwards Lifesciences's share price could reach $97.38 by Apr 27, 2027. The average Edwards Lifesciences stock price prediction forecasts a potential upside of 17.04% from the current EW share price of $83.20.

What is EW's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: EW) Edwards Lifesciences's current Earnings Per Share (EPS) is $1.89. On average, analysts forecast that EW's EPS will be $3.07 for 2026, with the lowest EPS forecast at $2.30, and the highest EPS forecast at $3.20. On average, analysts forecast that EW's EPS will be $3.44 for 2027, with the lowest EPS forecast at $2.59, and the highest EPS forecast at $3.69. In 2028, EW's EPS is forecast to hit $3.89 (min: $3.58, max: $4.27).

What is EW's forecast return on equity (ROE) for 2026-2029?

(NYSE: EW) forecast ROE is 23.82%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.